Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Eisai shares long-term data on lecanemab at neurology congress

Eisai shares long-term data on lecanemab at neurology congress
p p Read More

48-month analysis shows delayed progression and reduced risk in early Alzheimer’s patients

November 13, 2025 News

Mursla Bio partners with global pharma to advance precision medicine in liver disease

Mursla Bio partners with global pharma to advance precision medicine in liver disease
p p Read More

AI platform to support biomarker-guided therapy development in MASH

November 13, 2025 News

Flu in numbers: NHS faces one of worst winters ever, officials warn, amid concern over mutated strain

England is facing one of the toughest ever winters in its history as an early wave of flu […]

November 13, 2025 Uncategorized

Tuberculosis: Global deaths decline for first time since pandemic

Global efforts to tackle tuberculosis (TB) are starting to bear fruit, with the number of cases decreasing for […]

November 13, 2025 Uncategorized

Continued versus discontinued oral anticoagulant treatment for unprovoked venous thromboembolism: target trial emulation

AbstractObjectiveTo compare the effect on health outcomes of continuing or discontinuing oral anticoagulants (OACs) among patients with unprovoked […]

November 13, 2025 Uncategorized

How e-cigarettes compromise children’s human rights

In January 2024, a headteacher in an English school revealed that an e-cigarette detector alarm in his school […]

November 13, 2025 Uncategorized

Scarlett McNally: Understanding dying teaches us about living

My mother recently died peacefully at the age of 90. On her final morning she was briefly awake, […]

November 12, 2025 Geriatric medicine, Paediatrics, General practice / family medicine, UK, Shared decision making

Proposed changes to alcohol licensing should make us question whose interests we’re serving in the name of growth

Preventable ill health is at the heart of the challenges facing this country, incurring huge financial costs through […]

November 12, 2025 Uncategorized

Evotec earns milestone payment as FDA clears IND for CELMoD candidate

Evotec earns milestone payment as FDA clears IND for CELMoD candidate
p p Read More

US$5m payment from Bristol Myers Squibb marks progress in protein degradation partnership

November 12, 2025 News

Adocia unveils new long-acting peptide platform for diabetes and obesity

Adocia unveils new long-acting peptide platform for diabetes and obesity
p p Read More

Patent filed for AdoXLong with promising monthly injection potential

November 12, 2025 News

Posts navigation

Posts pagination

« Previous 1 2 3 4 … 1,907 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy